Our group demonstrated that TFF1 acts as a tumor suppressor in the progression of retinoblastoma by reducing RB cell viability, growth, and proliferation and increasing apoptosis in vitro as well as inhibiting tumor growth in vivo [22]. The gene discussed is RB1; the disease is neoplasm.